During the past decade, University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" are "Colon, Irritable" (2 trials), "Colonic Diseases, Functional" (1 trials), "Crohn's Disease" (1 trials), "Inflammation" (1 trials) and "Irritable Bowel Syndrome" (1 trials). Many other conditions were trialed in "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" in a lesser frequency.

Most popular intervention types in "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adacolumn" (1 trials), "Adacolumn Apheresis System" (1 trials) and "Sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".